Satellite Banner
Technology Networks Header
Wednesday, September 03, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Human Stem Cell-Derived Neural Progenitors & Neurons
Tuesday, December 03, 2013
Offers a platform to build human cellular models to study conditions like Alzheimer’s.

Enhanced General Purpose Centrifuge Product Line Increases Capacity and Flexibility
Tuesday, December 03, 2013
New enhanced general purpose centrifuge product line offers clinical and life science researchers the ability to spin more samples in a single run while maximizing critical lab space.

BMG LABTECH and InvivoSciences Initiate Market Collaboration
Friday, November 22, 2013
Collaboration to accelerate drug discovery in engineered 3D tissues.

Plasticell Announces CombiCult Patents
Monday, November 18, 2013
Additional family of CombiCult® patents granted in USA, Europe, Australia and Singapore.

Plasticell Announces CombiCult Patents
Monday, November 18, 2013
Additional family of CombiCult® patents granted in USA, Europe, Australia and Singapore.

Institut Curie Strengthens Pioneering Research with Innovative Biobanking Technology
Monday, November 18, 2013
TTP Labtech’s arktic system chosen for technical excellence and provision of long term sample security.

Oxford Optronix Launches HypoxyLab™
Thursday, November 14, 2013
HypoxyLab™ provides a physiologically reproducible, contamination-free, low oxygen/hypoxia environment to create optimal conditions for life science and clinical medicine research.

GE Healthcare Life Sciences Launches Xuri™ Technology Family
Wednesday, November 13, 2013
First product introduced - Xuri Cell Expansion System W25 for the clinical manufacture of cellular immunotherapies.

Low Profile Screw Caps Save Storage Space
Tuesday, November 05, 2013
New Low Profile Screw Caps available in 12 different colours.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 476
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv